Literature DB >> 6297697

The effect of naloxone and morphine on convulsions in mice following withdrawal from nitrous oxide.

H J Manson, G Dyke, J Melling, M Gough.   

Abstract

The incidence of withdrawal convulsions was determined in mice following removal from a 70 per cent nitrous oxide environment. Groups of 20 mice received saline (control), naloxone or morphine subcutaneous injections five minutes prior to withdrawal. The observer was blind to the treatments. In comparison to the control group, the proportion convulsing was significantly (p less than 0.05) increased following naloxone 0.125 mg (n = 40), 0.25 mg, but not 0.5 mg. The proportion convulsing was significantly decreased following morphine 0.4 mg. Overall proportions of mice convulsing was 0.55 for the saline control group; 0.73 for naloxone 0.125 mg; 0.80 for naloxone 0.25 mg; 0.60 for naloxone 0.50 mg; and 0.38 for morphine 0.4 mg. Modification of this phenomenon by both an opiate antagonist and agonist suggests endorphin withdrawal as a possible mechanism. However, this should be regarded as indirect evidence pending further study of this area.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297697     DOI: 10.1007/bf03007713

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  12 in total

Review 1.  On the specificity of naloxone as an opiate antagonist.

Authors:  J Sawynok; C Pinsky; F S LaBella
Journal:  Life Sci       Date:  1979-11-05       Impact factor: 5.037

2.  beta-endorphin is a potent analgesic agent.

Authors:  H H Loh; L F Tseng; E Wei; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

3.  Nitrous oxide effects on cerebral evoked potential to pain: partial reversal with a narcotic antagonist.

Authors:  C R Chapman; C Benedetti
Journal:  Anesthesiology       Date:  1979-08       Impact factor: 7.892

4.  Nitrous oxide stimulation of locomotor activity: evidence for an opiate-like behavioral effect.

Authors:  M D Hynes; B A Berkowitz
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

5.  Abortion and distribution of naloxone in rats after oral and intravenous administration.

Authors:  S H Weinstein; M Pfeffer; J M Schor; L Franklin; M Mintz; E R Tutko
Journal:  J Pharm Sci       Date:  1973-09       Impact factor: 3.534

6.  Nitrous oxide analgesia: reversal by naloxone and development of tolerance.

Authors:  B A Berkowitz; A D Finck; S H Ngai
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

7.  Physical dependence on nitrous oxide in mice: resemblance to alcohol but not to opiate withdrawal.

Authors:  B Milne; F W Cervenko; K H Jhamandas
Journal:  Can Anaesth Soc J       Date:  1981-01

8.  Antagonism of nitrous oxide analgesia by naloxone in man.

Authors:  J C Yang; W C Clark; S H Ngai
Journal:  Anesthesiology       Date:  1980-05       Impact factor: 7.892

9.  Nitrous oxide "analgesia": resemblance to opiate action.

Authors:  B A Berkowitz; S H Ngai; A D Finck
Journal:  Science       Date:  1976-11-26       Impact factor: 47.728

10.  Withdrawal convulsions in mice following nitrous oxide.

Authors:  M H Harper; P M Winter; B H Johnson; D D Koblin; E I Eger
Journal:  Anesth Analg       Date:  1980-01       Impact factor: 5.108

View more
  5 in total

Review 1.  Nitrous oxide.

Authors:  J T Jastak; D Donaldson
Journal:  Anesth Prog       Date:  1991 Jul-Oct

2.  Propofol-related convulsions.

Authors:  J C Bevan
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

3.  The opiate and antiopiate system: evidence for involvement in withdrawal responses.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Can Anaesth Soc J       Date:  1983-09

4.  Nitrous oxide analgesia in humans: acute and chronic tolerance.

Authors:  Douglas S Ramsay; Brian G Leroux; Marilynn Rothen; Christopher W Prall; Louis O Fiset; Stephen C Woods
Journal:  Pain       Date:  2005-03       Impact factor: 6.961

5.  Nitrous oxide and oral premedication.

Authors:  J A Giovannitti
Journal:  Anesth Prog       Date:  1984 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.